Evaluation of [18F]GATT-44 for Positron Emission Tomography Imaging of the GABA Transporter-1
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07457736
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Healthy Adult Participants
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- [ 18F]GATT-44 — DRUGFirst in human radiotracer being evaluated in this study.
Study Details
Evaluate \[18F\]GATT-44 (aka \[18F\]GAT44), to characterize its pharmacokinetic, metabolic, and in vivo binding profile, and assess the reproducibility of kinetic and binding parameters. Assess specific binding levels of \[18F\]GATT-44 by conducting a test-block study in humans. Estimate human dosimetry of \[18F\]GATT-44 by performing whole-body imaging studies.
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- Jan 2026
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2030
Study Design
- Enrollment
- 32 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Healthy Control - Test/RetestIn Part 1 we will conduct a test/retest study of the novel GABA Transporter (GAT-1) imaging tracer \[18F\]GATT44 in humans, to characterize its pharmacokinetic behavior and determine the reliability and reproducibility of in vivo pharmacokinetic parameter measurements
- Experimental: Healthy Control - Test-BlockingIn Part 2, we will conduct a test-blocking study to assess specific binding levels of \[18F\]GATT44 in humans.
- Experimental: Healthy Control - Whole BodyIn Part 3, human dosimetry of \[18F\]GATT44 will be estimated by performing whole-body imaging studies
Primary Outcome Measure
Test-Retest reproducibility calculations [ Time Frame: PET Day 1 and PET Day 2 ]
Central Contacts
- Shannan Henry+1 (203) 737-5278
- Kayla R Cottiers203-737-7496
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale University PET Center | New Haven | Connecticut | 06519 | Richard E Carson, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New Haven, CT
By research site
Related Studies
- A Usability Study of a Multi-channel ECG Monitoring DeviceNot Yet Recruiting · Wearlinq · New London, North Carolina
- Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.Not Yet Recruiting · Northern Illinois University · DeKalb, Illinois
- Kimchi and Gut HealthRecruiting · University of California, Davis · Davis, California
- A Study to Evaluate EDG-7500 in Caucasian and Japanese AdultsPHASE1 · Not Yet Recruiting · Edgewise Therapeutics, Inc. · Glendale, California